ST九有(600462) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥115,138,936.04, a decrease of 9.21% compared to the same period last year[2] - The net profit attributable to shareholders for Q3 2024 was -¥48,480,997.52, representing a significant decline of 3,017.55% year-over-year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥3,085,976.27, down 86.90% from the previous year[2] - The basic earnings per share for Q3 2024 was -¥0.0786, a decrease of 3,044.00% compared to the same period last year[3] - Net profit for the first three quarters of 2024 was a loss of ¥45,153,433.63, compared to a loss of ¥15,372,072.01 in the same period of 2023, indicating a worsening financial performance[18] - The net profit attributable to the parent company for Q3 2024 was -37,512,743.09 CNY, compared to -15,207,934.15 CNY in Q3 2023, indicating a significant increase in losses[19] - The total comprehensive income for Q3 2024 was -45,153,433.63 CNY, compared to -15,372,072.01 CNY in the same period last year[19] - The basic and diluted earnings per share for Q3 2024 were both -0.0608 CNY, worsening from -0.0259 CNY in Q3 2023[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥342,916,343.65, a decrease of 13.49% from the end of the previous year[3] - The company's total assets decreased to ¥342,916,343.65 from ¥396,390,272.80, reflecting a decline of approximately 13.5%[16] - Total liabilities amounted to ¥379,305,831.89, down from ¥410,191,367.90, representing a decrease of about 7.5%[16] - The company's equity attributable to shareholders showed a negative balance of ¥38,379,757.24, worsening from a negative ¥3,140,155.77 in the previous year[16] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥42,994,570.74, reflecting a decline of 201.70% compared to the previous year[3] - Cash inflows from operating activities for the first three quarters of 2024 were 422,905,100.02 CNY, up from 391,127,745.58 CNY in the same period of 2023[20] - The net cash flow from operating activities for the first three quarters of 2024 was -42,994,570.74 CNY, a decline from 42,277,561.42 CNY in the previous year[20] - The cash and cash equivalents at the end of Q3 2024 were 22,813,289.33 CNY, down from 45,030,247.21 CNY at the end of Q3 2023[21] - The company reported a significant increase in cash outflows related to operating activities, totaling 465,899,670.76 CNY in the first three quarters of 2024, compared to 348,850,184.16 CNY in the same period of 2023[20] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,410[8] - The largest shareholder, Lishui Lingnan Song Enterprise Management Partnership, held 11.31% of the shares, totaling 6,980,000 shares[8] Investments and Future Plans - The company plans to establish nine new subsidiaries in the dental medical equipment sector, although these have not yet commenced operations[12] - The company reported a long-term equity investment of ¥2,884,499.29 as of December 31, 2023, with no new updates provided in the latest report[14] - The company has no current plans for major asset restructuring or acquisitions in the same industry[12] Operating Costs and Expenses - Total operating revenue for the first three quarters of 2024 reached ¥363,085,387.21, a significant increase of 47.9% compared to ¥245,088,338.36 in the same period of 2023[16] - Total operating costs for the first three quarters of 2024 were ¥379,250,666.83, up 45.0% from ¥261,761,773.59 in the previous year[16] - The company reported a significant increase in sales expenses, which rose to ¥153,108,224.25 from ¥48,610,845.39, highlighting increased marketing efforts[18] Cash and Current Assets - As of September 30, 2024, the company's current assets totaled ¥222,020,679.97, a decrease of 15.1% from ¥261,503,487.56 on December 31, 2023[14] - Cash and cash equivalents decreased to ¥22,819,025.78 from ¥71,524,133.84, representing a decline of 68.1%[14] - Accounts receivable amounted to ¥90,195,378.58, down 21.4% from ¥114,655,117.80[14] - Prepayments increased significantly to ¥75,548,030.75, up 143.5% from ¥31,057,155.46[14] - Inventory rose to ¥27,084,071.81, an increase of 14.3% compared to ¥23,596,105.80[14] Non-Recurring Items - The company reported non-recurring gains and losses totaling -¥45,395,021.25 for the current period[5] - The company recognized an estimated liability of ¥50,666,781.86, which is expected to reduce the total profit for 2024 by the same amount[12] Research and Development - Research and development expenses were not detailed in the report, indicating a possible area for future investment focus[18]